Does USTEKINUMAB Cause Congestive cardiomyopathy? 29 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Congestive cardiomyopathy have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.0% of all adverse event reports for USTEKINUMAB.
29
Reports of Congestive cardiomyopathy with USTEKINUMAB
0.0%
of all USTEKINUMAB reports
6
Deaths
16
Hospitalizations
How Dangerous Is Congestive cardiomyopathy From USTEKINUMAB?
Of the 29 reports, 6 (20.7%) resulted in death, 16 (55.2%) required hospitalization, and 3 (10.3%) were considered life-threatening.
Is Congestive cardiomyopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Congestive cardiomyopathy?
SACUBITRIL\VALSARTAN (218)
DOXORUBICIN (204)
CYCLOPHOSPHAMIDE (180)
ROSIGLITAZONE (125)
CLOZAPINE (120)
QUETIAPINE (107)
EPIRUBICIN (95)
BISOPROLOL (92)
FUROSEMIDE (91)
RITUXIMAB (90)
Which USTEKINUMAB Alternatives Have Lower Congestive cardiomyopathy Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE